Idexx Laboratories reported $1.21B in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Abbott USD 13.01B 423M Sep/2026
Accuray USD 116.17M 14.63M Dec/2024
Align Technology USD 1.02B 40M Sep/2026
AngioDynamics USD 79.43M 3.72M Sep/2025
Dentsply International USD 836M 62M Sep/2026
Dexcom USD 1.34B 30M Sep/2026
Edwards Lifesciences USD 1.72B 20M Sep/2026
Fujifilm JPY 885.02B 58.53B Sep/2026
Globus Medical USD 763.72M 25.89M Sep/2026
Henry Schein USD 3.47B 10M Sep/2026
Idexx Laboratories USD 1.21B 10M Sep/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 842M 40.3M Sep/2026
Integra LifeSciences USD 411.18M 7.62M Sep/2026
Intuitive Surgical USD 3.05B 158.7M Sep/2026
Neogen USD 222.8M 2.5M Jun/2026
Orthofix International USD 219.91M 14.28M Dec/2025
Phibro Animal Health USD 373.91M 10.02M Dec/2025
ResMed USD 1.46B 60M Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Steris USD 1.59B 88.6M Sep/2026
Tandem Diabetes Care USD 283.69M 29.09M Sep/2026
Teleflex USD 567.8M 2.5M Sep/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
Zoetis USD 2.4B 100M Sep/2026